Psilocybin Therapy for Depression in Bipolar II Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.
Epistemonikos ID: b55b15edb08954c175f8b4aa758faa12b46e55ed
First added on: May 09, 2024